Biohaven completes $287.5M equity offering; 6.05M shares at $47.50

Biohaven Ltd.

Sold 6,052,631 common shares including full underwriter option at $47.50/share.
Gross proceeds ~$287.5M before underwriting discounts and expenses.
Underwriters were J.P. Morgan and Morgan Stanley; offering closed Oct. 2, 2024.
Prior to offering, Biohaven had 94,899,193 shares outstanding as of Sep. 30, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.